Vincent et al. discovered that the high expression of lysyl oxidase-like 4 (LOXL4) in CRC neutrophils is considered to be the key factor that leads to the resistance to antiangiogenic therapy, revealing a new mechanism of LOXL4 in neutrophil-mediated angiogenesis [128]. The gene discussed is LOXL4; the disease is colorectal carcinoma.